eISSN: 2449-8580
ISSN: 1734-3402
Family Medicine & Primary Care Review
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2024
vol. 26
 
Share:
Share:
Review paper

Mobile health applications for self-regulation of glucose levels in type 2 diabetes mellitus patients: a systematic review

Sitti Syabariyah
1
,
Puput Putri Kusuma Wardani
1
,
Popy Siti Aisyah
1
,
Urfa Khairatun Hisan
2

  1. Faculty of Health Sciences, Universitas ‘Aisyiyah Bandung, Bandung, Indonesia
  2. Faculty of Medicine, Universitas Ahmad Dahlan, Yogyakarta, Indonesia
Family Medicine & Primary Care Review 2024; 26(1): 123–136
Online publish date: 2024/03/15
Get citation
 
PlumX metrics:
 
1. Tinajero MG, Malik VS. An update on the epidemiology of type 2 diabetes: a global perspective. Endocrinol Metab Clin North Am 2021; 50(3): 337–355.
2. Noubiap JJ, Nansseu JR, Nyaga UF, et al. Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2·3 million patients with tuberculosis. Lancet Glob Health 2019; 7(4): e448–e460.
3. Ma CX, Ma XN, Guan CH, et al. Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management. Cardiovasc Diabetol 2022; 21(1): 74, doi: 10.1186/s12933-022-01516-6.
4. Alicic RZ, Rooney MT, Tuttle KR. Diabetic Kidney Disease: Challenges, Progress, and Possibilities. Clin J Am Soc Nephrol 2017; 12(12): 2032–2045, doi: 10.2215/CJN.11491116.
5. Stefánsson E, Bek T, Porta M, et al. Screening and prevention of diabetic blindness. Acta Ophthalmol Scand 2000; 78(4): 374–385.
6. Barnes JA, Eid MA, Creager MA, et al. Epidemiology and risk of amputation in patients with diabetes mellitus and peripheral artery disease. Arterioscler Thromb Vasc Biol 2020; 40(8): 1808–1817.
7. Haskas Y, Rizkiani I, Restika I. Literature review: evaluasi metode diabetes self management education (DSME) pada penderita diabetes melitus type 2. Nursing Arts 2020; 14(2): 127–141.
8. Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes Res Clin Pract 2019; 157: 107843.
9. Syabariyah S, Nurachmah E, Widjojo BD, et al. The Effect of Vibration on the Acceleration of Wound Healing of Diabetic Neuropathic Foot Ulcer: A Prospective Experimental Study on Human Patients. Healthcare 2023; 11(2): 191, doi: 10.3390/healthcare11020191.
10. Yunir E, Tahapary DL, Tarigan TJE, et al. Non-vascular contributing factors of diabetic foot ulcer severity in national referral hospital of Indonesia. J Diabetes Metab Disord 2021; 20(1): 805–813.
11. Adam JM. Komplikasi kronik diabetik masalah utama penderita diabetes dan upaya pencegahan. Jurnal Kedokteran Universitas Hasanudin 2005; 26(3): 53–61 (in Indonesian).
12. Anwar MC. Cek Daftar Kenaikan UMP Jakarta dari Tahun ke Tahun. Kompas [Internet]. 2021 Nov 7 [cited 17.11.2022]. Available from URL: mon-ey.kompas.com/read/2022/11/28/125127126/cek-daftar-kenaikan-ump-dki-jakarta-dari-tahun-ke-tahun (in Indonesian).
13. Andriyanto A, Hidayati RN. Literature review: pemanfaatan media promosi kesehatan (smartphone) dalam mencegah dan mengendalikan kadar gula diabetes tipe 2. Jurnal Ners dan Kebidanan 2018; 5(2): 172–177 (in Indonesian).
14. Tomky D, Cypress M, Dang D, et al. AADE7TM self-care behaviors. Diabetes Educ 2008; 34(3): 445–449.
15. Association AD. Standards of medical care in diabetes – 2009. Diabetes Care 2009; 32(Suppl. 1): S13.
16. Goodall TA, Halford WK. Self-management of diabetes mellitus: a critical review. Health Psychol 1991; 10(1): 1–8.
17. Tristiana RD. Keefektifan Intervensi Psikologis: Motivational Interviewing Program untuk Meningkatkan Manajemen Diri dan Kontrol Glikemik pada Pasien Diabetes Mellitus Tipe 2. Jurnal Ners Lentera 2016; 4(2): 166–177.
18. Widyaningsih DS, Prasetyowati AT, Harwanto A, et al. Newspaper Leg Exercise to Reduce the Type 2 Diabetes Mellitus Physical Symptoms. Journal of Health Sciences and Medical Development 2022; 1(2): 83–91.
19. García-Pérez LE, Álvarez M, Dilla T, et al. Adherence to therapies in patients with type 2 diabetes. Diabetes Ther 2013; 4: 175–194.
20. AlHewiti A. Adherence to long-term therapies and beliefs about medications. Int J Family Med 2014; 2014: 479596, doi: 10.1155/2014/479596.
21. World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: WHO; 2003.
22. Moynihan R, Sanders S, Michaleff ZA, et al. Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic review. BMJ Open 2021; 11(3): e045343.
23. Banerjee M, Chakraborty S, Pal R. Diabetes self-management amid COVID-19 pandemic. Diabetes Metab Syndr 2020; 14(4): 351–354.
24. Galiero R, Pafundi PC, Nevola R, et al. The importance of telemedicine during COVID-19 pandemic: a focus on diabetic retinopathy. J Diabetes Res 2020; 2020: 9036847, doi: 10.1155/2020/9036847.
25. Mohseni M, Ahmadi S, Azami-Aghdash S, et al. Challenges of routine diabetes care during COVID-19 era: a systematic search and narrative review. Prim Care Diabetes 2021; 15(6): 918–922.
26. Yang Y, Shang W, Rao X. Facing the COVID-19 outbreak: What should we know and what could we do? J Med Virol 2020; 92(6): 536–537.
27. López Seguí F, Franch Parella J, Gironès García X, et al. A cost-minimization analysis of a medical record-based, store and forward and provider-to-provider telemedicine compared to usual care in Catalonia: more agile and efficient, especially for users. Int J Environ Res Public Health 2020; 17(6): 2008, doi: 10.3390/ijerph17062008.
28. Vidal-Alaball J, Acosta-Roja R, Pastor Hernández N, et al. Telemedicine in the face of the COVID-19 pandemic. Aten Primaria 2020; 52(6): 418–422, doi: 10.1016/j.aprim.2020.04.003.
29. Alromaihi D, Alamuddin N, George S. Sustainable diabetes care services during COVID-19 pandemic. Diabetes Res Clin Pract 2020; 166: 108298, doi: 10.1016/j.diabres.2020.108298.
30. Franc S, Daoudi A, Mounier S, et al. Telemedicine and diabetes: Achievements and prospects. Diabetes Metab 2011; 37(6): 463–476.
31. Bashshur RL, Shannon GW, Smith BR, et al. The empirical evidence for the telemedicine intervention in diabetes management. Telemed J E Health 2015; 21(5): 321–354.
32. McDonnell ME. Telemedicine in complex diabetes management. Curr Diab Rep 2018; 18(7): 42, doi: 10.1007/s11892-018-1015-3.
33. Marcolino MS, Maia JX, Alkmim MBM, et al. Telemedicine application in the care of diabetes patients: systematic review and meta-analysis. PLoS ONE 2013; 8(11): e79246.
34. Lee JY, Lee SWH. Telemedicine cost-effectiveness for diabetes management: a systematic review. Diabetes Technol Ther 2018; 20(7): 492–500.
35. Shan R, Sarkar S, Martin SS. Digital health technology and mobile devices for the management of diabetes mellitus: state of the art. Diabetologia 2019; 62: 877–887.
36. Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015; 4(1): 1–9.
37. Elm E, von, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for re-porting observational studies. Ann Intern Med 2007; 147(8): 573–577.
38. Cuschieri S. The STROBE guidelines. Saudi J Anaesth 2019; 13(Suppl. 1): S31–S34.
39. Long HA, French DP, Brooks JM. Optimising the value of the critical appraisal skills programme (CASP) tool for quality appraisal in qualitative evidence syn-thesis. Research Methods in Medicine & Health Sciences 2020; 1(1): 31–42.
40. CASP. Critical Appraisal Skills Programme [Internet]. CASP UK. 2023 [cited 1.03.2023]. Available from URL: https://casp-uk.net/.
41. Patnaik L, Panigrahi SK, Sahoo AK, et al. Mobile health application based intervention for improvement of quality of life among newly diagnosed type 2 diabetes patients. Clin Diabetol 2021; 10(3): 276–283.
42. Young HM, Miyamoto S, Dharmar M, et al. Nurse coaching and mobile health compared with usual care to improve diabetes self-efficacy for persons with type 2 diabetes: randomized controlled trial. JMIR Mhealth Uhealth 2020; 8(3): e16665.
43. Poonprapai P, Lerkiatbundit S, Saengcharoen W. Family support-based intervention using a mobile application pro-vided by pharmacists for older adults with diabetes to improve glycaemic control: a randomised controlled trial. Int J Clin Pharm 2022; 44(3): 680–688, doi: 10.1007/s11096-022-01389-5.
44. Lee EY, Yun JS, Cha SA, et al. Personalized type 2 diabetes management using a mobile application integrated with electronic medical records: an ongoing randomized controlled trial. Int J Environ Res Public Health 2021; 18(10): 5300, doi: 10.3390/ijerph18105300.
45. Kebede MM, Schuett C, Pischke CR. The role of continuous glucose monitoring, diabetes smartphone applications, and self-care behavior in glycemic control: results of a multi-national online survey. J Clin Med 2019; 8(1): 109 doi: 10.3390/jcm8010109.
46. Yamaguchi S, Waki K, Nannya Y, et al. Usage patterns of GlucoNote, a self-management smartphone app, based on ResearchKit for patients with type 2 diabetes and prediabetes. JMIR Mhealth Uhealth 2019; 7(4): e13204.
47. Joshua SR, Abbas W, Lee JH. M-Healthcare Model: An Architecture for a Type 2 Diabetes Mellitus Mobile Application. Appl Sci 2023; 13(1): 8, doi: 10.3390/app13010008.
48. Abd-alrazaq AA, Suleiman N, Baagar K, et al. Patients and healthcare workers experience with a mobile application for self-management of diabetes in Qatar: A qualitative study. Computer Methods and Programs in Biomedicine Update 2021; 1: 100002, doi: 10.1016/j.cmpbup.2021.100002.
49. Rossmann C, Riesmeyer C, Brew-Sam N, et al. Appropriation of mobile health for diabetes self-management: lessons from two qualitative studies. JMIR Diabetes 2019; 4(1): e10271, doi: 10.2196/10271.
50. Jeffrey B, Bagala M, Creighton A, et al. Mobile phone applications and their use in the self-management of type 2 diabetes mellitus: a qualitative study among app users and non-app users. Diabetol Metab Syndr 2019; 11(1): 1–17.
51. Adu MD, Malabu UH, Malau-Aduli AEO, et al. User retention and engagement with a mobile app intervention to support self-management in Australians with type 1 or type 2 diabetes (my care hub): mixed methods study. JMIR Mhealth Uhealth 2020; 8(6): e17802.
52. Adu MD, Malabu UH, Malau-Aduli AEO, et al. The development of My Care Hub mobile-phone app to support self-management in Australians with type 1 or type 2 diabetes. Sci Rep 2020; 10(1): 1–10.
53. Izahar S, Lean QY, Hameed MA, et al. Content analysis of mobile health applications on diabetes mellitus. Front Endocrinol (Lausanne) 2017; 8: 318.
54. Hisan UK, Irianto I, Ghazali I, et al. Telemedicine and COVID-19 Pandemic: Valuable Lessons for Future Implementa-tions. JNEST 2022; 1(2): 63–68.
55. Rahmini JA, Rahayuningtyas DK. Inovasi Kesehatan Terkini Sebagai Strategi Efektif Pada Manajemen Diabetes Di Masa Pandemi: Sebuah Tinjauan Literature. JKEP 2020; 5(2): 196–211.
56. Wahyudi CT. Aplikasi M-Health Dalam Upaya Monitoring Perawatan Pada Pasien Diabetes Mellitus: Studi Literatur. Jurnal JKFT 2019; 4(2): 1–10.
57. Andriyanto A, Hidayati RN. Literature review: pemanfaatan media promosi kesehatan (smartphone) dalam mencegah dan mengendalikan kadar gula Diabe-tes Tipe 2. Jurnal Ners dan Kebidanan 2018; 5(2): 172–177 (in Indonesian).
Copyright: © 2024 Family Medicine & Primary Care Review. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.